Literature DB >> 1478311

Non-traumatic mycotic keratitis.

L W Hirst1, A Sebban, R M Whitby, G R Nimmo, K Stallard.   

Abstract

Two patients presented with culture proven Paecilomyces corneal infection, and a further patient with histologic evidence of fungal infection, on deep corneal biopsy. In all three cases the corneal infection was macroscopically present only in the depth of the cornea and on the endothelial surface with an intact epithelium and no overlying stromal involvement. Repeated surgery with large corneo-scleral grafts in two cases, and with medical therapy and a small patch-graft alone in the third case, resulted in long-term eradication of the infection and preservation of the globes. Antecedent modulation with steroid and/or cyclophosphamide may well have delayed the diagnosis, however, as there was no history of trauma in any of these cases, we postulate that these infections were not exogenously derived.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478311     DOI: 10.1038/eye.1992.80

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

1.  Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole.

Authors:  Michael A Arnoldner; Ahmad Kheirkhah; Frederick A Jakobiec; Marlene L Durand; Pedram Hamrah
Journal:  Cornea       Date:  2014-07       Impact factor: 2.651

2.  Paecilomyces keratitis.

Authors:  L W Hirst
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

3.  Medical management of suspected Paecilomyces sp. deep keratitis.

Authors:  Lee Holland; Graham A Lee
Journal:  BMJ Case Rep       Date:  2015-07-01

4.  Corneoscleral transplantation for end stage corneal disease.

Authors:  L W Hirst; G A Lee
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

5.  Retrospective case-series of Paecilomyces lilacinus ocular mycoses in Queensland, Australia.

Authors:  Liam Daniel Turner; Diana Conrad
Journal:  BMC Res Notes       Date:  2015-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.